Navigation Links
Listen-up ladies: Don't postpone knee-replacement surgery
Date:1/9/2008

Is getting new knees on your list of New Year's resolutions?

Research at the University of Delaware indicates that women wait longer to pursue knee-replacement surgery than men do.

By postponing surgery until they can no longer stand the pain, these women may also risk putting their mobility, and quality of life, on hold indefinitely, according to Lynn Snyder-Mackler, Distinguished Alumni Professor in UD's Department of Physical Therapy and a certified sports physical therapist and athletic trainer.

Doctors typically tell patients to wait to have knee replacements until they just can't stand the pain any longer, Snyder-Mackler said. Our research shows that's bad advice--and worse for women than it is for men--because your level of function going into surgery generally dictates your level of function after surgery, she noted.

Snyder-Mackler led the research team for the study, which was funded by a $1,125,000 million grant from the National Institutes of Health. Her collaborators included Stephanie Petterson, who earned her doctorate in physical therapy and was a postdoctoral researcher at UD and is now a senior lecturer at the University of East London, and Drs. Leo Raisis and Alex Bodenstab, orthopedic surgeons at First State Orthopaedics in Newark, Del.Stephanie Petterson.

At UD's Physical Therapy Clinic in McKinly Laboratory, 229 candidates for total knee replacements, including 95 men and 126 women with osteoarthritis, were evaluated and compared to 44 healthy men and women who matched them in gender, age and body-mass index. Each subject took part in a series of standard physical tests such as stair climbing and the distance covered in a six-minute walk.

The strength of the participants' quadriceps--the major thigh muscle that extends and straightens the knee--and range of motion of the knee also were assessed at the UD clinic, which handles more than 300 visits by patients each week.


'/>"/>
Contact: Tracey Bryant
tbryant@udel.edu
302-831-8185
University of Delaware
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Minimally invasive heart surgery research wins NIH award
2. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
3. BMI criteria for obesity surgery should be lowered, UT Southwestern researcher suggests
4. Surgery without stitches
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Listen-up ladies: Don't postpone knee-replacement surgery
Listen-up ladies: Don't postpone knee-replacement surgery
(Date:12/3/2009)... a social snubbing? Your genetics, not your friends, may be ... called opioids, relieve not only physical pain, but also some ... Faculty of 1000 Biology member Markus Heilig shows that small ... determine the intensity of people,s responses to social rejection. ...
(Date:12/3/2009)... NY A team of scientists from the U.S. ... and the Indian Institute of Science has made a ... information in DNA that is necessary to carry out ... 1, 2009 edition of Nature Structural & Molecular ...
(Date:12/2/2009)... evidence that people who smoke cigarettes over a long ... colorectal cancer, even after adjusting for other risk factors. ... smoke, or to quit as soon as possible," said ... emeritus, epidemiology and surveillance research at the American Cancer ...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2HBA Global Announces Finalists for the 2009 International Package Design Awards 28IPDA 29 55290 1HBA Global Announces Finalists for the 2009 International Package Design Awards 28IPDA 29 55290 2HBA Global Announces Finalists for the 2009 International Package Design Awards 28IPDA 29 55290 3CardioDx Completes Validation Study of First Of Its Kind Genomic Test for Coronary Artery Disease 4894 1CardioDx Completes Validation Study of First Of Its Kind Genomic Test for Coronary Artery Disease 4894 2CardioDx Completes Validation Study of First Of Its Kind Genomic Test for Coronary Artery Disease 4894 3CardioDx Completes Validation Study of First Of Its Kind Genomic Test for Coronary Artery Disease 4894 4Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 1Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 2Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 3Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 4
... India accelerates, tobacco advertising and marketing have been linked to ... 11, according to a study by researchers at The University ... Associations Between Tobacco Marketing and Use Among Urban Youth In ... Journal of Health Behavior. , Findings from an ...
... Inc. (OTC,Bulletin Board: STIY), a leader in electro-stun ... agreement with the Securities and Exchange,Commission., Stinger ... admitting or,denying wrongdoing and has agreed to an ... that no fines or monetary,sanctions were levied against ...
... and more of them are dying in West Greenland as ... a Penn State associate professor of biology. Post, who ... climate changes including global warming, based his conclusions on data ... corresponds to the timing of caribou births. The study, ...
Other Biology News:UT researchers find link between advertising and increased tobacco use among India's youth 2UT researchers find link between advertising and increased tobacco use among India's youth 3Global warming linked to caribou-calf mortality 2
(Date:12/3/2009)... (LSE: SHP, Nasdaq: SHPGY ), the global specialty ... lots and voluntary market withdrawal of one lot of ... is taking this action because some Daytrana patches do ... their release liner removal specification, and as a result, ...
(Date:12/3/2009)... -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer ... ), spoke at a conference on High-Risk Diabetic,Foot ... Beike is China,s leading,stem cell research and regenerative ... conference, organized by the Indian Podiatry Association (IPA), ...
(Date:12/2/2009)... YORK, Dec. 2 Reportlinker.com announces that ... in its catalogue: ,, Carbondioxide Incubators ... http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators are ... genetics, cancer, research, and other applications for ...
(Date:12/2/2009)... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion ... trial of Cotara® in patients with relapsed glioblastoma multiforme ... is a targeted monoclonal antibody linked to a radioisotope ... Cotara specifically targets cells at the center of ...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... Oct. 11 AMDL, Inc. (Amex:,ADL), headquartered ... and Jilin, China, through its wholly owned ... biopharma company that,engages in the development, manufacture ... AMDL announced today that JPI has,signed an ...
... Combined cardiac and vascular tissue processing revenues in the third, quarter ... 2006 ... FDA completes re-inspection, ATLANTA, Oct. 11 CryoLife, Inc. (NYSE: ... that product and preservation services revenues for the third quarter,of 2007 ...
... Nodal T-Cell Lymphoma Summary: Genmab Announced Today it has ... Refractory CTCL and has Received an Orphan Drug ... of Nodal T-Cell Lymphoma, COPENHAGEN, Denmark, October 11 ... of the ongoing pivotal,study of HuMax-CD4(R) (zanolimumab) to treat refractory ...
Other Biology Technology:AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually 2CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 2CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 3CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 4CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 5Genmab Amends HuMax-CD4 Pivotal Study in CTCL 2Genmab Amends HuMax-CD4 Pivotal Study in CTCL 3
Peptide-affinity Purified Polyclonal Antibody to Retinoic Acid-Induced 3 (RAI3/RAIG1)...
Biotin anti-human CD164...
Can be used for the quantitative recovery of small amounts of nucleic acids within dilute solutions. 5mg/ml...
EDTA, 0.5 M solution, 100 ml. Ethylene diaminetetraacetic acid.Sterile, nuclease-free. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: